ANTI-THYMOCYTE GLOBULIN (ATG) CAN ELIMINATE PLATELET REFRACTORINESS

被引：8
|
作者：
SABBE, LJM
CLAAS, FHJ
HAAK, HL
VANGEMERT, GW
JANSEN, J
ZWAAN, FE
TRICOT, G
NITERINK, A
LANGERAK, J
VANROOD, JJ
机构：
[1] UNIV LEIDEN,MED CTR,DEPT HAEMATOL,2333 AA LEIDEN,NETHERLANDS
[2] UNIV LEIDEN,MED CTR,DEPT VIROL,2333 AA LEIDEN,NETHERLANDS
来源：
BLUT | 1981年 / 42卷 / 06期
关键词：
D O I：
10.1007/BF00996895
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：331 / 335
页数：5
相关论文
共 50 条
  • [21] INHIBITION OF HELPER T-CELL FUNCTION BY ANTI-THYMOCYTE GLOBULIN (ATG)
    HELDERMAN, JH
    GAILIUNAS, P
    LIPSKY, P
    CLINICAL RESEARCH, 1979, 27 (02): : A327 - A327
  • [22] Efficacy of Rabbit Anti-Thymocyte Globulin (ATG) Compared to Horse ATG In Severe Aplastic Anemia.
    Afable, Manuel, II
    Shaik, Mohammed
    Sugimoto, Yuka
    Clemente, Michael
    Tiu, Ramon V.
    Mohan, Sanjay R.
    Bejanyan, Nelli
    Elson, Paul
    Kalaycio, Matt
    Advani, Anjali
    Sobecks, Ronald
    Lichtin, Alan E.
    Sekeres, Mikkael A.
    Maciejewski, Jaroslaw
    BLOOD, 2010, 116 (21) : 919 - 920
  • [23] EFFECTS OF ANTI-THYMOCYTE GLOBULIN (ATG) ON IMMUNOLOGICAL DISORDERS OF NZB-NZW MICE
    HAHN, B
    CLINICAL RESEARCH, 1975, 23 (04): : A491 - A491
  • [24] ANTI-THYMOCYTE GLOBULIN INDUCED THROMBOCYTOPENIA
    LAZARCHICK, J
    RUSSELL, R
    HORN, B
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 1990, 20 (06): : 373 - 378
  • [25] Anti-thymocyte globulin (ATG) preserves ventricular function after experimental myocardial infarction
    Rauch, Moritz
    Hoetzenecker, Konrad
    Hasun, Matthias
    Baumgartner, Andrea
    Hacker, Stefan
    Werba, Gregor
    Klepetko, Walter
    Podesser, Bruno Karl
    Ankersmit, Hendrik Jan
    Lichtenauer, Michael
    WIENER KLINISCHE WOCHENSCHRIFT, 2010, 122 (17-18) : A20 - A20
  • [26] INDIVIDUALIZED MONITORING AND MODULATION OF IMMUNE REACTIVITY USING STANDARDIZED ANTI-THYMOCYTE GLOBULIN (ATG)
    THOMAS, F
    MENDEZPICON, G
    THOMAS, J
    LEE, HM
    TRANSPLANTATION PROCEEDINGS, 1979, 11 (02) : 1429 - 1430
  • [27] Risk factors for early hepatic cytolysis during treatment with anti-thymocyte globulin (ATG)
    Aldweik, B.
    Redjoul, R.
    Bastuji-Garin, S.
    Beckerich, F.
    Robin, C.
    Pautas, C.
    Toma, A.
    Cabanne, L.
    Maury, S.
    Cordonnier, C.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S207 - S208
  • [28] Anti-thymocyte globulin therapy (ATG) in a patient with pANCA vasculitis and crescentic glomerulonephritis.
    Keller, F
    Lukas, R
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A2644 - A2644
  • [29] RADIOIMMUNOASSAY FOR ANTI-THYMOCYTE GLOBULIN ACTIVITY
    CISEK, J
    DONEY, K
    LOBUGLIO, A
    CLINICAL RESEARCH, 1979, 27 (04): : A643 - A643
  • [30] Therapy of early stage myelodysplastic syndrome (MDS) with anti-thymocyte globulin (ATG) and etanercept
    Scott, Bart L.
    Holsinger, Aaron L.
    Ramakrishnan, Aaravind
    Storer, Barry
    Becker, Pamela S.
    Petersdorf, Stephen
    Deeg, H. Joachim
    BLOOD, 2007, 110 (11) : 438A - 438A
12345